Correlation between Prostatic Volume and International Prostatic Symptom Score in Patients with Benign Prostatic Hyperplasia

Hafsa Sadiq; Rizwan  Bilal; Mobeen  Shafique; Sana  Waqar; Qurat Ul Ain  Ghazanfar; Sehrish  Azam

doi:10.51253/pafmj.v74i6.7154

Authors

Hafsa Sadiq Department of Radiology, Armed Forces Institute of Radiology and Imaging/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
Rizwan Bilal Department of Radiology, Armed Forces Institute of Radiology and Imaging/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
Mobeen Shafique Department of Radiology, Combined Military Hospital Pano Aqil/National University of Medical Sciences (NUMS) Pakistan,
Sana Waqar Department of Radiology, Armed Forces Institute of Radiology and Imaging/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
Qurat Ul Ain Ghazanfar Combined Military Hospital Lahore/National University of Medical Sciences (NUMS) Pakistan
Sehrish Azam Department of Radiology, Armed Forces Institute of Radiology and Imaging/National University of Medical Sciences (NUMS), Rawalpindi Pakistan

DOI:

https://doi.org/10.51253/pafmj.v74i6.7154

Keywords:

Lower Urinary Tract Symptoms, Prostatic Hyperplasia, Severity of Illness Index, Ultrasonography.

Abstract

Objective: To determine the correlation between transabdominal ultrasound prostatic volume and International Prostatic Symptom Score in patients with benign prostatic hyperplasia.

Study Design: Cross-sectional study.

Place and Duration of Study: Armed Forces Institute of Radiology and Imaging, Rawalpindi Pakistan, from Sep 2020 to Apr 2021.

Methodology: Forty five patients were enrolled after taking informed consent. Detailed history was taken and all patients were assessed using the International Prostate Symptom Score. Findings were noted on a predesigned proforma after which all patients were prepared for transabdominal ultrasound in order to achieve bladder volume of at least 50 to 99 ml. Subsequently, transabdominal ultrasound was carried out for determining the volume of the prostate and all findings were subjected to statistical analysis.

Results: Mean age of patients was 66.6±9.91 years, with the mean International Prostate Symptom Score being 20.53±9.84 and volume of prostate being 59.56±27.18 cc. Five patients (11.1%) had mild symptoms, 15(33.6%) had moderate and 25(55.6%) had severe symptoms. With regards to volume of prostate, Grade I, II, III and IV was seen in 6(13.3%), 7(15.6%), 20(44.4%) and 12(26.7%) patients respectively. Significant positive correlation was seen between prostatic volume and International Prostate Symptom Score as indicated by an r=0.437 and p=0.003.

Conclusion: Transabdominal prostatic volume was found to be significantly correlated with International Prostate Symptom Score, and can be used as an objective assessment of symptoms severity.

Downloads

Download data is not yet available.

References

Lerner LB, McVary KT, Barry MJ, Bixler BR, Dahm P, Das AK, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline part II—surgical evaluation and treatment. J Urol 2021; 206(4): 818-826.

https://doi.org/10.1097/JU.0000000000002184

Agrawal CS, Chalise PR, Bhandari BB. Correlation of prostate volume with international prostate symptom score and quality of life in men with benign prostatic hyperplasia. Neurol Med Chir 2008; 10(2): 104-107.

Ofoha CG, Shu'aibu SI, Akpayak IC, Dakum NK, Ramyil VM. Relationship between prostate volume and IPSS in African men with prostate disease. Jos J Med 2015; 9(1): 16-19.

Awaisu M, Ahmed M, Lawal AT, Sudi A, Tolani MA, Oyelowo N, et al Correlation of prostate volume with severity of lower urinary tract symptoms as measured by international prostate symptoms score and maximum urine flow rate among patients with benign prostatic hyperplasia. Afr J Urol 2021; 27(1): 1-7.

https://doi.org/10.1186/s12301-021-00122-4

Gnyawali D, Sharma U. Correlation of prostate volume with'International Prostate Symptom Score'and'Benign Prostatic Hyperplasia-Impact Index in benign prostatic hyperplasia. J Soc Surg Nepal 2014; 17(1): 6-10.

https://doi.org/10.3126/jssn.v17i1.15174

Eze BU, Mbaeri TU, Oranusi KC, Abiahu JA, Nwofor AM, Orakwe JC, et al. Correlation between intravesical prostatic protrusion and international prostate symptom score among Nigerian men with benign prostatic hyperplasia. Niger J Clin Pract 2019; 22(4): 454.

https://www.njcponline.com/text.asp?2019/22/4/454/255921

Udeh EI, Ozoemena OF, Ogwuche E. The relationship between prostate volume and international prostate symptom score in Africans with benign prostatic hyperplasia. Niger J Med 2012; 21(3): 290-295.

Alawad AA, Elamin SM, Younis FH. Correlation between prostate volume and lower urinary tract symptoms in Sudanese patients with benign prostatic hyperplasia. J Basic Res Med Sci 2015; 4(4): 121-124.

Udoh EA, Eyo AE, Ekwere PD. The most bothersome lower urinary tract symptom affecting quality of life using international prostate symptom score in patients with benign prostate hyperplasia. Ibom Med J 2020; 13(1): 43-49.

https://doi.org/10.61386/imj.v13i1.178

Azhar A, Nugroho EA, Gunadi EE. Relationship between Prostate Volume and International Prostate Symptom Score (IPSS) Degree of Tamed Prostate Enlargement on Transabdominal Ultrasonography (TAUS) and Transrectal Ultrasonography (TRUS) Examination. Indones Biomed J 2021; 7(1): 112-117.

https://doi.org/10.32539/BJI.v7i1

Hossain MA, Islam MW, Naser MF, Azam MS. Correlation of international prostate symptom score with Intravesical protrusion of prostate in patients with benign enlargement of prostate. Bangladesh J Urol 2020; 22(2): 151-154.

https://doi.org/10.3329/bju.v22i2.50103

Massanova M, Robertson S, Barone B, Dutto L, Caputo VF, Bhatt JR, et al. The comparison of imaging and clinical methods to estimate prostate volume: a single-centre retrospective study. Urol Int 2021; 105(9-10): 804-810.

https://doi.org/10.1159/000516681

Bhomi KK, Joshi BR. Correlation between symptom severity and objective parameters in elderly men with lower urinary tract symptoms. Nepal Med Col J 2019; 21(2): 117-121.

https://doi.org/10.3126/nmcj.v21i2.25110

Ugraiah AB, Shyam S. Correlation of international prostate symptom score and uroflowmetry in evaluation of benign prostatic hyperplasia. Int Surg J 2020; 7(10): 3381-3388.

http://doi.org/10.18203/2349-2902.isj20204141

Bassey IA, Isiwele EM, Eyam SE, Ushie DE, Ani NE. Correlation of international prostate symptom score with prostate volume and quality of life in a screened population of university workers. Int J Cont Med Res 2018; 5(1): 15-17.

Anwar M, Saifullah M, Malik MT, Munir MI, Akmal M, Subhani GM, et al Correlation between bladder wall thickness and IPSS in patients having benign prostatic hyperplasia. Professional Med J 2020; 27(12): 2553-2557.

https://doi.org/10.29309/TPMJ/2020.27.12.5021

Roehrborn CG. Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH). Med Clin 2011; 95(1): 87-100.

https://doi.org/10.1016/j.mcna.2010.08.013

Bosch JL, Hop WC, Kirkels WJ, Schröder FH. The International Prostate Symptom Score in a community‐based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. Br J Urol 1995; 75(5): 622-630.

https://doi.org/10.1111/j.1464-410X.1995.tb07421.x